Sharescart Research Club logo

Cravatex Overview

Cravatex Limited was established in 1951 by Ram Kumar Batra and is part of The Batra Group. It operates in the sports and lifestyle industry. They distribute and market international sports and fitness brands in India. At first, Cravatex owned the largest chain of dyers and dry cleaners in India and subsequently diversified into Garment Export, Textile Processing and Printing. The company was taken public on the Bombay Stock Exchange in 1979 and continues to be listed after more than four decades. Cravatex hosts a number of renowned brands like...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Cravatex Key Financials

Market Cap ₹92 Cr.

Stock P/E 19

P/B 0.8

Current Price ₹355

Book Value ₹ 441

Face Value 10

52W High ₹555

Dividend Yield 3.52%

52W Low ₹ 300

Cravatex Share Price

| |

Volume
Price

Cravatex Quarterly Price

Show Value Show %

Cravatex Peer Comparison

Cravatex Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 57 38 51 26 55 32 61 23 51 37
Other Income 6 6 3 3 2 2 2 5 4 5
Total Income 63 44 53 29 57 35 63 28 55 41
Total Expenditure 60 42 53 28 53 34 60 29 49 39
Operating Profit 4 2 1 1 4 0 3 -1 7 2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 1 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 3 1 0 1 4 -0 2 -1 6 2
Provision for Tax 0 1 -0 0 1 -0 1 0 1 0
Profit After Tax 3 1 1 0 3 0 1 -1 5 1
Adjustments -0 0 -0 0 0 0 0 0 0 0
Profit After Adjustments 3 1 1 0 3 0 1 -1 5 1
Adjusted Earnings Per Share 12 3 2 1.9 10.3 1 5.6 -5.3 20.2 5.2

Cravatex Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 233 255 266 356 718 865 532 594 504 203 174 172
Other Income 3 3 4 4 4 5 14 15 12 16 10 16
Total Income 235 257 270 360 722 870 546 610 516 219 184 187
Total Expenditure 218 249 271 361 694 843 544 598 534 210 175 177
Operating Profit 17 8 -1 -1 28 26 2 12 -17 8 8 11
Interest 10 13 11 5 6 14 15 14 14 0 0 0
Depreciation 4 3 3 6 6 15 17 16 16 2 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 106 0 0 0
Profit Before Tax 3 -7 -15 -12 17 -2 -30 -19 58 6 6 9
Provision for Tax 1 1 -1 0 6 2 1 1 -1 1 2 2
Profit After Tax 2 -8 -14 -12 11 -5 -31 -20 59 5 5 6
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 -8 -14 -12 11 -5 -31 -20 59 5 5 6
Adjusted Earnings Per Share 9.2 -30.7 -53.7 -47.7 41.3 -18.2 -118.4 -77 228 18.7 18.7 25.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -14% -34% -27% -3%
Operating Profit CAGR 0% -13% -21% -7%
PAT CAGR 0% 0% 0% 10%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -11% 5% 5% 4%
ROE Average 5% 95% 57% 15%
ROCE Average 7% 27% 14% 9%

Cravatex Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 44 36 22 9 20 -1 -28 -50 92 99 106
Minority's Interest 0 0 0 0 -0 71 75 75 0 0 0
Borrowings 13 9 80 83 84 83 84 106 0 0 0
Other Non-Current Liabilities 9 9 8 9 8 45 37 27 2 3 3
Total Current Liabilities 98 120 110 107 188 244 217 205 43 23 31
Total Liabilities 164 175 220 208 299 442 385 365 137 124 141
Fixed Assets 29 28 46 41 41 86 70 55 3 4 4
Other Non-Current Assets 6 5 9 9 11 15 13 15 8 5 5
Total Current Assets 129 142 164 158 247 341 302 295 126 115 131
Total Assets 164 175 220 208 299 442 385 365 137 124 141

Cravatex Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 7 57 6 7 39 35 38 56 74
Cash Flow from Operating Activities 0 0 35 -13 -5 32 -4 -8 144 19 3
Cash Flow from Investing Activities 0 0 -24 -4 3 -37 21 14 42 -1 -1
Cash Flow from Financing Activities 0 0 38 -34 -0 37 -21 -4 -168 -0 -1
Net Cash Inflow / Outflow 0 0 50 -51 -2 32 -4 3 18 17 2
Closing Cash & Cash Equivalent 0 0 57 6 4 39 35 38 56 74 75

Cravatex Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 9.23 -30.66 -53.66 -47.74 41.26 -18.24 -118.45 -76.95 228.05 18.68 18.68
CEPS(Rs) 23.68 -18.01 -40.51 -25.55 63.44 39.72 -50.96 -13.62 290.52 25.97 24.4
DPS(Rs) 2 0 0 1 2 3 3 3 1.5 3 12.5
Book NAV/Share(Rs) 169.55 138.89 83.09 36.1 76.53 -3.96 -109.44 -192.58 357.42 382.02 411.83
Core EBITDA Margin(%) 6.2 2.27 -1.74 -1.58 3.35 2.46 -2.23 -0.55 -5.93 -3.77 -0.97
EBIT Margin(%) 5.75 2.04 -1.69 -1.99 3.14 1.33 -2.82 -0.74 14.32 3.24 3.9
Pre Tax Margin(%) 1.43 -2.89 -5.7 -3.4 2.35 -0.28 -5.59 -3.12 11.58 3.04 3.67
PAT Margin (%) 1.03 -3.11 -5.21 -3.47 1.49 -0.55 -5.76 -3.35 11.7 2.38 2.78
Cash Profit Margin (%) 2.63 -1.83 -3.93 -1.86 2.28 1.19 -2.48 -0.59 14.91 3.31 3.63
ROA(%) 1.47 -4.68 -7.03 -5.76 4.2 -1.27 -7.4 -5.31 23.51 3.7 3.64
ROE(%) 5.53 -19.88 -48.34 -80.11 73.26 -50.28 0 0 276.7 5.05 4.71
ROCE(%) 12.16 4.77 -3.41 -5.24 17.96 7.78 -10.5 -3.59 68.8 6.87 6.62
Receivable days 116.83 105.34 92.45 84.27 64.41 67.43 107.22 84.83 57.77 36.08 39.71
Inventory Days 67.38 75.15 67.17 39.95 30.51 34.9 57.17 55.07 44.71 35.77 23.26
Payable days 66.65 63.82 65.07 68.32 29.81 19.47 32.59 27.99 30.99 40.41 38.15
PER(x) 53.66 0 0 0 6.9 0 0 -4.69 1.4 23.4 18.34
Price/Book(x) 2.92 1.64 4.34 10.61 3.72 -81.81 -2.65 -1.87 0.9 1.14 0.83
Dividend Yield(%) 0.4 0 0 0.26 0.7 0.93 1.03 0.83 0.47 0.69 3.65
EV/Net Sales(x) 0.82 0.48 0.64 0.55 0.26 0.23 0.36 0.37 0.05 0.18 0.08
EV/Core EBITDA(x) 11.11 14.53 -155.28 -146.07 6.54 7.36 79.61 18.55 -1.51 4.37 1.58
Net Sales Growth(%) -4.62 9.54 4.46 33.71 101.7 20.48 -38.49 11.74 -15.26 -59.77 -14.25
EBIT Growth(%) -8.23 -61.12 -186.58 -57.47 418.05 -48.9 -230.38 70.85 1748.93 -90.9 3.31
PAT Growth(%) -51.07 -432.15 -74.99 11.02 186.42 -144.22 -549.26 35.03 396.33 -91.81 0.02
EPS Growth(%) -51.07 -432.15 -74.98 11.02 186.42 -144.21 -549.31 35.03 396.34 -91.81 0.02
Debt/Equity(x) 1.52 2 6.27 11.26 5.9 -157.02 -5.47 -3.36 0 0 0
Current Ratio(x) 1.32 1.18 1.49 1.48 1.32 1.4 1.39 1.43 2.95 5.11 4.22
Quick Ratio(x) 0.82 0.71 1.11 1.14 0.87 1.06 1 0.97 2.27 4.64 3.86
Interest Cover(x) 1.33 0.41 -0.42 -1.41 3.99 0.83 -1.02 -0.31 5.22 16.1 16.41
Total Debt/Mcap(x) 0.52 1.22 1.44 1.06 1.59 1.92 2.06 1.79 0 0 0

Cravatex Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 75 75 75 75 75 75 75 75 75 75
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 25 25 25 25 25 25 25 25 25 25
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Cravatex News

Cravatex Pros & Cons

Pros

  • Stock is trading at 0.8 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 95%
  • Debtor days have improved from 40.41 to 38.15days.
  • Company is almost debt free.

Cons

whatsapp